From: Molecular mechanism of circRNAs in drug resistance in renal cell carcinoma
circRNA | Target | Function | References |
---|---|---|---|
circPUM1 | miR-340-5p/FABP7 | Induced RCC’s progression | ZENG et al. [25] |
circ‐ZNF609 | miR‐138‐5p/FOXP4 | Induced RCC’s progression | Xiong et al. [26] |
circPTCH1 | miR-485-5p/MMP14 | Induced RCC’s progression | Liu et al. [27] |
circPCNXL2 | miR‐153/ZEB2 | Induced RCC’s progression | Zhou et al. [28] |
circRNA_001287 | miR-144/CEP55 | Induced RCC’s progression | Feng et al. [29] |
circRNA SCARB1 | miR- 510-5p/SDC3 | Induced RCC’s progression | Sun et al. [30] |
circTLK1 | miR-136-5p | Induced RCC’s progression | Li et al. [31] |
cRAPGEF5 | miR-27a-3p/TXNIP | Suppressed RCC’s progression | Chen et al. [36] |
hsa-circ-0072309 | miR-100/PI3K/AKT and mTOR | Suppressed RCC’s progression | Tao et al. [37] |
circ‐AKT3 | miR‐296‐3p/E‐cadherin | Suppressed RCC’s progression | XUE et al. [38] |
circUBAP2 | miR-148a-3P/FOXK2 | Suppressed RCC’s progression | SUN et al. [39] |
circHIPK3 | miR-637 | Suppressed RCC’s progression | Li et al. [40] |
hsa_circ_0035483 | hsa-miR-335/CCNB1 | Enhanced RCC’s resistance to gemcitabine | Yan et al. [57] |
circSNX6 | miR-1184/GPCPD1 | Enhanced RCC’s resistance to sunitinib | Huang et al. [58] |
circRNA-001895 | miR-296-5P/FOX2 | Enhanced RCC’s resistance to sunitinib | Tan et al. [59] |
circEHD2 | miR-4731-5p/ABCF2 | Enhanced RCC’s resistance to sunitinib | Li et al. [61] |
circME1 | malic enzyme 1 | Enhanced RCC’s resistance to sunitinib | Zhang et al. [63] |